|
|
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期1986-03-01 |
A Phase III, Randomized, Double Blind, Non-inferiority, Comparative Study of the New Transdermal Patch Dosage Form Containing Loxoprofen Sodium (100 mg) and Loxonin® (60 mg Tablet) for the Treatment of Acute Traumatic Injuries
This study evaluates the non-inferiority of the new transdermal patch dosage form containing loxoprofen sodium (100 mg - Daiichi-Sankyo) in comparison with oral Loxonin® (60 mg tablet - Daiichi-Sankyo) for the treatment of acute traumatic injuries.
100 项与 Daiichi Sankyo Brasil Farmacêutica Ltda. 相关的临床结果
0 项与 Daiichi Sankyo Brasil Farmacêutica Ltda. 相关的专利(医药)
100 项与 Daiichi Sankyo Brasil Farmacêutica Ltda. 相关的药物交易
100 项与 Daiichi Sankyo Brasil Farmacêutica Ltda. 相关的转化医学